Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process.
Ahmed AA, Otten AT, Gareb B, Huijmans JE, Eissens AC, Rehman A, Dijkstra G, Kosterink JGW, Frijlink HW, Schellekens RCA. Ahmed AA, et al. Among authors: otten at. Pharmaceutics. 2023 Apr 28;15(5):1354. doi: 10.3390/pharmaceutics15051354. Pharmaceutics. 2023. PMID: 37242596 Free PMC article.
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
Bourgonje AR, Alexdottir MS, Otten AT, Loveikyte R, Bay-Jensen AC, Pehrsson M, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Karsdal MA, Faber KN, Mortensen JH, Dijkstra G. Bourgonje AR, et al. Among authors: otten at. Aliment Pharmacol Ther. 2022 Aug;56(4):675-693. doi: 10.1111/apt.17063. Epub 2022 Jun 6. Aliment Pharmacol Ther. 2022. PMID: 35661188 Free PMC article.
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease.
Otten AT, Bourgonje AR, Horinga PP, van der Meulen HH, Festen EAM, van Dullemen HM, Weersma RK, van Leer-Buter CC, Dijkstra G, Visschedijk MC. Otten AT, et al. Front Immunol. 2022 Jul 5;13:920333. doi: 10.3389/fimmu.2022.920333. eCollection 2022. Front Immunol. 2022. PMID: 35865529 Free PMC article.
The effect of riboflavin supplementation on the systemic redox status in healthy volunteers: A post-hoc analysis of the RIBOGUT trial.
Bourgonje AR, Otten AT, Sadaghian Sadabad M, von Martels JZH, Bulthuis MLC, Faber KN, van Goor H, Dijkstra G, Harmsen HJM. Bourgonje AR, et al. Among authors: otten at. Free Radic Biol Med. 2022 Sep;190:169-178. doi: 10.1016/j.freeradbiomed.2022.08.008. Epub 2022 Aug 13. Free Radic Biol Med. 2022. PMID: 35973668 Free article. Clinical Trial.
Effects of ileocolonic delivered vitamin B2, B3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial.
Otten AT, Peters V, Barth I, Stevens CL, Bourgonje AR, Frijlink HW, Harmsen HJM, Rehman A, Campmans-Kuijpers MJE, Dijkstra G. Otten AT, et al. BMJ Open. 2023 Mar 14;13(3):e069654. doi: 10.1136/bmjopen-2022-069654. BMJ Open. 2023. PMID: 36918234 Free PMC article.
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
Otten AT, van der Meulen HH, Steenhuis M, Loeff FC, Touw DJ, Kosterink JGW, Frijlink HW, Rispens T, Dijkstra G, Visschedijk MC, Bourgonje AR. Otten AT, et al. Inflamm Bowel Dis. 2024 Mar 1;30(3):325-335. doi: 10.1093/ibd/izad103. Inflamm Bowel Dis. 2024. PMID: 37265165 Free PMC article.
14 results